% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • windtime24 windtime24 Nov 14, 2011 10:52 AM Flag

    The Pharmasset playbook

    SGP WAS fudging on Victrelis trial data. Right now VRUS is less than complete with the data they are releasing and it brings about suspicion. It may well turn out that VRVS has just what they claim to have. They are riding the wave of success, and VRTX has taken a big hit as a result. With more complete data VRUS could be the one taking the hit and VRTX could regain darling status. We'll just have to wait and see. At the very least, I'll give VRUS credit for making a great stride in the science of treating Hep C.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
131.97-1.16(-0.87%)Nov 25 4:00 PMEST